Titan Pharmaceuticals, Inc.

4.6100-0.18 (-3.76%)

Oct 1, 4:00:00 PM EDT · NasdaqCM · TTNP · USD

Upcoming Earnings

Report date

≈ -

Key Stats

Market Cap

6.13M

P/E (TTM)

Basic EPS (TTM)

-2.92

Dividend Yield

Recent Filings

8-K

10/1/25Oct 1, 2025

8-K

8/26/25Aug 26, 2025

10-Q

8/14/25Aug 14, 2025

8-K

6/27/25Jun 27, 2025

8-K

6/18/25Jun 18, 2025

About

As of October 1, 2025, Titan Pharmaceuticals, Inc. was acquired by KE Sdn Bhd, in a reverse merger transaction. Titan Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development of therapeutics for the treatment of chronic diseases. Titan Pharmaceuticals, Inc. was founded in 1991 and is based in New York, New York.

CEO

Mr. Weei Jye Chay

IPO

1/18/1996

Website

https://www.titanpharm.com

Sector

Healthcare

Industry

Biotechnology